Healthcare

Shares of Neuren Pharmaceuticals Ltd (ASX:NEU) surged 18% to AU$10.83 in morning trade, marking one of the biotech sector's performances to kick off the week. The sharp rally follows a significant regulatory milestone that could bring the company closer to launching a world-first treatment …

Argenica Therapeutics Limited (ASX:AGN), a clinical-stage biotechnology company developing neuroprotective therapeutics, has successfully completed dosing of all patients in its Phase 2 clinical trial evaluating ARG-007 in patients with acute ischaemic stroke (AIS).

Shares of Netwealth Group Ltd (ASX:NWL) rallied 10% on Thursday to AU$24.93, as investors responded positively to a standout quarterly update and a supportive tech rally on Wall Street. The surge follows the company's release of its March 2025 quarter results, which revealed record …

Shares of Australian protective gear manufacturer Ansell Ltd (ASX:ANN) fell by as much as 2.7% on Wednesday, trading at AU$28.60 after Macquarie Group lowered its rating on the stock and revised its price target downward. The downgrade comes amid concerns over newly announced U.S. …

Shares of Cochlear (ASX: COH) made a modest recovery today, up 0.4%, after experiencing a 2.6% decline earlier in the day. The hearing aid maker’s gains follow news that its implants will remain exempt from U.S. import duties, providing some relief to the company. …

Orthocell Ltd (ASX:OCC), the Australian regenerative medicine company, has placed its shares into a trading halt as it awaits a pivotal decision from the U.S. Food and Drug Administration (FDA) regarding regulatory clearance for its flagship Remplir nerve repair product.

Shares of Australian medical gear maker Ansell Ltd (ASX:ANN) rose 4.02% during afternoon trade on Friday, recovering some ground after a sharp selloff in the previous session saw the stock plunge as much as 16.4%. The rebound followed the company’s assurance that it will …